These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7. Czeczuga-Semeniuk E, Wolczyński S, Dziecioł J, Dabrowska M, Anchim T, Tomaszewska I. Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438 [Abstract] [Full Text] [Related]
3. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells? Czeczuga-Semeniuk E, Anchim T, Dziecioł J, Dabrowska M, Wołczyński S. Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735 [Abstract] [Full Text] [Related]
5. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Wouters W, van Dun J, Dillen A, Coene MC, Cools W, De Coster R. Cancer Res; 1992 May 15; 52(10):2841-6. PubMed ID: 1581897 [Abstract] [Full Text] [Related]
6. Estradiol and tamoxifen differently affects the inhibitory effects of vitamin A and their metabolites on the proliferation and expression of alpha2beta1 integrins in MCF-7 breast cancer cells. Czeczuga-Semeniuk E, Lemancewicz D, Wołczyński S. Adv Med Sci; 2009 May 15; 54(1):91-8. PubMed ID: 19581203 [Abstract] [Full Text] [Related]
7. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Strobl JS, Kirkwood KL, Lantz TK, Lewine MA, Peterson VA, Worley JF. Cancer Res; 1990 Sep 01; 50(17):5399-405. PubMed ID: 2386945 [Abstract] [Full Text] [Related]
8. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7. Butler WB, Fontana JA. Cancer Res; 1992 Nov 15; 52(22):6164-7. PubMed ID: 1423259 [Abstract] [Full Text] [Related]
11. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. Cucina A, Proietti S, D'Anselmi F, Coluccia P, Dinicola S, Frati L, Bizzarri M. J Pineal Res; 2009 Mar 15; 46(2):172-80. PubMed ID: 19175854 [Abstract] [Full Text] [Related]
13. Effect of retinoic acid on proliferation of estrogen-responsive transformed murine Leydig cells in serum-free culture. Hirose T, Koga M, Kouhara H, Kishimoto S, Matsumoto K, Sato B. Cancer Res; 1990 Aug 15; 50(16):5060-4. PubMed ID: 2165854 [Abstract] [Full Text] [Related]
14. Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: proteomic characterization. Wang Y, He QY, Chen H, Chiu JF. Exp Cell Res; 2007 Jan 15; 313(2):357-68. PubMed ID: 17098229 [Abstract] [Full Text] [Related]
15. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach. Girgert R, Bartsch C, Hill SM, Kreienberg R, Hanf V. Neuro Endocrinol Lett; 2003 Dec 15; 24(6):440-4. PubMed ID: 15073572 [Abstract] [Full Text] [Related]
16. All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells. Danforth DN. J Endocrinol; 2004 Nov 15; 183(2):395-404. PubMed ID: 15531727 [Abstract] [Full Text] [Related]
17. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction. Liu XH, Zheng XF, Wang YL. Chin Med J (Engl); 2009 Jul 20; 122(14):1681-5. PubMed ID: 19719971 [Abstract] [Full Text] [Related]
18. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Chen J, Power KA, Mann J, Cheng A, Thompson LU. Exp Biol Med (Maywood); 2007 Sep 20; 232(8):1071-80. PubMed ID: 17720953 [Abstract] [Full Text] [Related]
20. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation. Jawed S, Kim B, Ottenhof T, Brown GM, Werstiuk ES, Niles LP. Eur J Pharmacol; 2007 Mar 29; 560(1):17-22. PubMed ID: 17303109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]